tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market
Want to see ACTU full AI Analyst Report?

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

36 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$2.31
$79.19M
-7.81
-64.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$4.79
$143.99M
-2.62
27.12%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$3.06
$155.83M
-3.37
75.48%
5 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$3.47
$224.57M
-1.25
68.45%
5 Buy
0 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.92
$290.78M
-1.93
98.67%
5 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$9.93
$562.93M
-2.93
360.40%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
3.34
-7.01
-67.73%
AGEN
Agenus
3.75
0.84
28.87%
BDTX
Black Diamond Therapeutics
2.72
1.08
65.85%
NKTX
Nkarta
3.15
1.22
63.21%
CCCC
C4 Therapeutics
2.98
1.51
102.72%
KYTX
Kyverna Therapeutics, Inc.
9.30
7.19
340.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts